Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1975 Oct;34(5):438–443. doi: 10.1136/ard.34.5.438

Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

J Holian, I D Griffiths, D N Glass, R N Maini, J T Scott
PMCID: PMC1006445  PMID: 1221924

Abstract

A technique for the measurement of DNA binding activity of sera is described which uses primary internal reference standards in a Farr assay. This allows the DNA binding activity of test sera to be measured in relation to the reference standards and the results are expressed as units/ml. The use of this standardized assay has led to diminished interassay variation and close interlaboratory correlation, and has provided a clinically useful test. In survey using the standardized assay, normal sera were found to have binding activity which did not exceed 15 units/ml; 71% of patients with systemic lupus erythematosus (SLE) had levels greater than 25 units/ml; while only 8% of patients with diseases other than SLE had levels above 25 units/ml. Values between 15 and 25 units/ml appeared to have little diagnostic significance.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CEPPELLINI R., POLLI E., CELADA F. A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus. Proc Soc Exp Biol Med. 1957 Dec;96(3):572–574. doi: 10.3181/00379727-96-23544. [DOI] [PubMed] [Google Scholar]
  2. Carr R. I., Koffler D., Agnello V., Kunkel H. G. Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate. Clin Exp Immunol. 1969 May;4(5):527–536. [PMC free article] [PubMed] [Google Scholar]
  3. Cohen S. A., Hughes G. R., Noel G. L., Christian C. L. Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1971 Apr;8(4):551–561. [PMC free article] [PubMed] [Google Scholar]
  4. DEICHER H. R., HOLMAN H. R., KUNKEL H. G. The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus. J Exp Med. 1959 Jan 1;109(1):97–114. doi: 10.1084/jem.109.1.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
  6. Hasselbacher P., LeRoy E. C. Serum DNA binding activity in healthy subjects and in rheumatic disease. Arthritis Rheum. 1974 Jan-Feb;17(1):63–71. doi: 10.1002/art.1780170110. [DOI] [PubMed] [Google Scholar]
  7. Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
  8. Pincus T. Immunochemical conditions affecting the measurement of DNA antibodies using ammonium sulfate precipitation. Arthritis Rheum. 1971 Sep-Oct;14(5):623–630. doi: 10.1002/art.1780140509. [DOI] [PubMed] [Google Scholar]
  9. Pincus T., Schur P. H., Rose J. A., Decker J. L., Talal N. Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969 Sep 25;281(13):701–705. doi: 10.1056/NEJM196909252811304. [DOI] [PubMed] [Google Scholar]
  10. ROBBINS W. C., HOLMAN H. R., DEICHER H., KUNKEL H. G. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med. 1957 Dec;96(3):575–579. doi: 10.3181/00379727-96-23545. [DOI] [PubMed] [Google Scholar]
  11. Rochmis P. G., Palefsky H., Becker M., Roth H., Zvaifler N. J. Native DNA binding in rheumatoid arthritis. Ann Rheum Dis. 1974 Jul;33(4):357–360. doi: 10.1136/ard.33.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schur P. H., Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med. 1968 Mar 7;278(10):533–538. doi: 10.1056/NEJM196803072781004. [DOI] [PubMed] [Google Scholar]
  13. Wold R. T., Young F. E., Tan E. M., Farr R. S. Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid. Science. 1968 Aug 23;161(3843):806–807. doi: 10.1126/science.161.3843.806. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES